• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二线抗结核药物对耐多药结核分枝杆菌临床分离株的敏感性模式

Sensitivity Pattern of Second Line Anti-Tuberculosis Drugs against Clinical Isolates of Multidrug Resistant Mycobacterium tuberculosis.

作者信息

Ghafoor Tahir, Ikram Aamer, Abbasi Shahid Ahmad, Zaman Gohar, Ayyub Muhammad, Palomino Juan Carlos, Vandamme Peter, Martin Anandi

机构信息

Department of Microbiology, Armed Forces Institute of Pathology (AFIP), Rawalpindi.

Department of Haematology, Armed Forces Institute of Pathology (AFIP), Rawalpindi.

出版信息

J Coll Physicians Surg Pak. 2015 Apr;25(4):250-3.

PMID:25899188
Abstract

OBJECTIVE

To determine the current sensitivity pattern of second line anti-tuberculosis drugs against clinical isolates of Multidrug Resistant Mycobacterium tuberculosis (MDR-TB).

STUDY DESIGN

A cross-sectional study.

PLACE AND DURATION OF STUDY

Department of Microbiology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, from November 2011 to April 2013.

METHODOLOGY

Samples received during the study period were processed on BACTEC MGIT 960 system for Mycobacterium tuberculosis (MTB) culture followed by first line drugs susceptibility testing of culture proven MTB isolates. On the basis of resistance to rifampicin and isoniazid, 100 clinical isolates of MDR-TB were further subjected to susceptibility testing against amikacin (AMK), capreomycin (CAP), ofloxacin (OFL) and ethionamide (ETH) as per standard BACTEC MGIT 960 instructions.

RESULTS

Out of 100 MDR-TB isolates, 62% were from male patients and 38% from female patients. 97% were sensitive to AMK, 53% to OFL, 87% to CAP; and 87% were sensitive to ETH.

CONCLUSION

The majority of the MDR-TB isolates showed excellent sensitivity against AMK, CAP and ETH. However, sensitivity of MDR-TB isolates against fluoroquinolones like OFL was not encouraging.

摘要

目的

确定二线抗结核药物对耐多药结核分枝杆菌(MDR-TB)临床分离株的当前敏感性模式。

研究设计

横断面研究。

研究地点和时间

2011年11月至2013年4月,拉瓦尔品第武装部队病理研究所(AFIP)微生物学系。

方法

在研究期间收到的样本在BACTEC MGIT 960系统上进行结核分枝杆菌(MTB)培养,随后对培养证实的MTB分离株进行一线药物敏感性测试。根据对利福平和平的耐药性,按照标准的BACTEC MGIT 960说明,对100株MDR-TB临床分离株进一步进行对阿米卡星(AMK)、卷曲霉素(CAP)、氧氟沙星(OFL)和乙硫异烟胺(ETH)的敏感性测试。

结果

在100株MDR-TB分离株中,62%来自男性患者,38%来自女性患者。97%对AMK敏感,53%对OFL敏感,87%对CAP敏感;87%对ETH敏感

结论

大多数MDR-TB分离株对AMK、CAP和ETH表现出优异的敏感性。然而,MDR-TB分离株对OFL等氟喹诺酮类药物的敏感性并不乐观。

相似文献

1
Sensitivity Pattern of Second Line Anti-Tuberculosis Drugs against Clinical Isolates of Multidrug Resistant Mycobacterium tuberculosis.二线抗结核药物对耐多药结核分枝杆菌临床分离株的敏感性模式
J Coll Physicians Surg Pak. 2015 Apr;25(4):250-3.
2
In Vitro Evaluation of Linezolid and Meropenem Against Clinical Isolates of Multi Drug Resistant Tuberculosis By Mycobacterial Growth Indicator Tube (MGIT) 960.采用分枝杆菌生长指示管(MGIT)960对利奈唑胺和美罗培南针对耐多药结核临床分离株进行的体外评估
J Coll Physicians Surg Pak. 2015 Jun;25(6):427-30.
3
Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).使用经典二线药物(左氧氟沙星和阿米卡星)的耐多药结核病临床分离株中的广泛耐药和准广泛耐药结核病
J Coll Physicians Surg Pak. 2015 May;25(5):337-41.
4
Multi-drug resistant tuberculosis in Northern Pakistan.巴基斯坦北部的耐多药结核病
J Pak Med Assoc. 2004 Sep;54(9):469-72.
5
Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省吡嗪酰胺耐药情况
Microb Drug Resist. 2018 Nov;24(9):1417-1421. doi: 10.1089/mdr.2017.0234. Epub 2018 Mar 27.
6
A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border.墨西哥/美国边境高负担地区一线和二线耐药结核病的基于人群的研究。
Mem Inst Oswaldo Cruz. 2013 Apr;108(2):160-6. doi: 10.1590/0074-0276108022013006.
7
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.耐多药结核分枝杆菌临床分离株中的二线抗结核药物耐药性及其遗传决定因素
J Microbiol Immunol Infect. 2016 Jun;49(3):439-44. doi: 10.1016/j.jmii.2015.04.003. Epub 2015 May 15.
8
[Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].[采用E-test法评估耐多药结核分枝杆菌复合群分离株的二线抗结核药物敏感性]
Mikrobiyol Bul. 2015 Jan;49(1):47-55. doi: 10.5578/mb.8602.
9
First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.埃塞俄比亚西北部的一线和二线抗结核药物耐药性。
Int J Tuberc Lung Dis. 2012 Jun;16(6):805-11. doi: 10.5588/ijtld.11.0522. Epub 2012 Feb 29.
10
Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: Implications for disease control.2010 - 2014年巴基斯坦结核分枝杆菌分离株对氟喹诺酮类药物的耐药性:对疾病控制的影响。
Int J Mycobacteriol. 2015 Mar;4 Suppl 1:47-8. doi: 10.1016/j.ijmyco.2014.10.046. Epub 2014 Dec 22.

引用本文的文献

1
Adverse treatment outcomes in multidrug resistant tuberculosis go beyond the microbe-drug interaction: Results of a multiple correspondence analysis.耐多药结核病的不良治疗结局不仅仅与微生物-药物相互作用有关:一项多元对应分析的结果。
Biomedica. 2020 Dec 2;40(4):616-625. doi: 10.7705/biomedica.5072.